A systematic review and economic evaluation of the use of tumour necrosis factor-alpha (TNF-α) inhibitors, adalimumab and infliximab, for crohn's disease

J. Dretzke, R. Edlin, J. Round, M. Connock, C. Hulme, J. Czeczot, A. Fry-Smith, C. McCabe, C. Meads*

*Corresponding author for this work

Research output: Contribution to journalArticle (Academic Journal)peer-review

87 Citations (Scopus)

Fingerprint Dive into the research topics of 'A systematic review and economic evaluation of the use of tumour necrosis factor-alpha (TNF-α) inhibitors, adalimumab and infliximab, for crohn's disease'. Together they form a unique fingerprint.

Medicine & Life Sciences